Constructs a cross domain data set and computes a distance matrix and performs hierarchical clustering of subjects across all of the study centers to identify pairs of subjects with a very small distance. This could be an indication that these subjects are in fact the same individual who has enrolled at multiple sites. Constructs a cross domain data set and computes a distance matrix and performs hierarchical clustering of subjects within each study center to identify pairs of subjects with a very small distance. This could be an indication that these subject are slightly modified copies of one another. Adding data for various domains to the ADSL table corresponding to incidence of variables in the AE , CM , LB , and MH domains and a summary statistic for LB , EG , and VS domain values Calculating Mahalanobis distance based on available data to detect subject inliers and outliers in multivariate space, and generating results by site to see which sites are extremeReports examining patient demographics and study visit attendance are described in the table below:.
Compares distributions of demographic variables across treatment arms via a one-way ANOVA or contingency analysis. Compares the distributions of study visit days for each center compared to all other centers combined, and identifies unusual differences.
Fitting Bayesian hierarchical models for adverse events, while taking into account a grouping variable Screening adverse events by performing a Cochran-Mantel-Haenszel exact test on all 2x2 tables constructed from incidence and treatment arm Screening adverse events by performing a Cochran-Mantel-Haenszel test on all 2x2 tables constructed from event resolution and treatment arm Screening adverse events by performing a mixed-model analysis of variance , with average ranked severity score as the dependent variable and customizable fixed and random effects Creating Kaplan-Meier Survival Curves for time to study discontinuation and associated statistics, grouped by treatment arm Screening events from a domain by performing a Cochran-Mantel-Haenszel test on all 2x2 tables constructed from event incidence and treatment armNote : This process should be considered as two : DS Incidence Screen and MH Incidence Screen , depending on which domain is specified in the dialog. Grouping clinical mortality results by treatment arm and generating Kaplan-Meier Survival Curves with associated statistics
Screening findings measurements for a specified domain one at a time by performing a repeated-measures analysis of variance Displaying Box Plot s by treatment group representing the change from baseline in measurements for each test for a specified findings domain across various time windows or points in a study Displaying Shift Plot s to compare test measurements for a specified findings domain at baseline versus on-therapy values, and performing a matched pairs analysis on average score during baseline and a summary score during the trial Visualizing findings measurements across the timeline of a study Creating waterfall plots to show the distribution of changes in test measurements for a given Findings domain across subjects Visualizing peak values for lab measurements pertaining to Hy’s Law for detecting potential liver toxicity for all subjects across treatment arms
Generating an exposure summary and plot for all subjects in a study of an investigational product, by dose and exposure time for the safety population , by treatment Screening interventions by performing a Cochran-Mantel-Haenszel exact test on all 2x2 tables constructed from event incidence and treatment armClick on a button corresponding to an interventions process. Refer to the table below for guidance.
Defines a new risk threshold data set used to 1) define the risk levels for individual variables for RBM analyses, and 2) specify the contribution of each variable to overall indicators of site risk. Opens a JMP table listing the latitude and longitude of more than 750,000 geographical locations worldwide, spread over either1) U.S. Cities , or 2) Non-U.S. Cities to help individuals customize geographic information in Update Study Risk Data Set in order to geocode clinical trial sites.
Note : Some processes require that a JMP table be open and in focus, with desired patients selected, prior to execution.
Generating a subject filter that is applied to all subsequent processes run on the data for a study 1 Removing a subject filter from the current studyClick the button to open the Disproportionality Analysis process, which screens an adverse event data set and performs data mining analyses for pharmacovigilance and signal detection.Click on a button corresponding to a subject utility . Refer to the table below for guidance..
Click on a button corresponding to a subject utility . Refer to the table below for guidance..
Checks SAS data sets in the SDTM and ADaM folders that have been specified for the selected study, for all variables required for various JMP Clinical reports.